Why the Lone EpiPen Competitor Hasn’t Taken Off

Photo of Why the Lone EpiPen Competitor Hasn’t Taken Off
Facebook
VKontakte
share_fav

Adrenaclick, a cheaper alternative, has benefited from furor over EpiPen pricing. But its maker is struggling to meet demand, and a generic EpiPen is near.

view The New York Times: Business
#epipen
#medical devices
#mylan inc
#adrenaclick
#generic brands and products
#impax laboratories